Insights

Strategic Partnerships Quell Therapeutics has established strategic partnerships with industry giants like AstraZeneca, presenting sales opportunities for collaboration on cell-based treatments for autoimmune diseases.

Cutting-Edge Technology Utilizing advanced technologies such as Python, Microsoft, and Google, Quell Therapeutics is at the forefront of innovation, offering potential sales prospects in tech solutions tailored for biotechnology research.

Notable Personnel With the recent appointment of Luke Devey as Chief Medical Officer, Quell Therapeutics has strengthened its leadership team, creating opportunities for business engagements led by experienced healthcare professionals.

Growing Markets As Quell Therapeutics expands its cell therapy portfolio for autoimmune diseases like Type 1 Diabetes and Inflammatory Bowel Disease, there are emerging sales prospects in the rapidly growing market segment of personalized medicine and immunotherapy.

Financial Stability Having secured significant funding and a revenue range of $10M - $50M, Quell Therapeutics exhibits financial stability, indicating potential opportunities for sales engagements without concerns over immediate financial risks.

Quell Therapeutics Tech Stack

Quell Therapeutics uses 8 technology products and services including jsDelivr, Neo4j, ADP, and more. Explore Quell Therapeutics's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Neo4j
    Database
  • ADP
    Human Resource Management System
  • Slick
    Javascript Libraries
  • Google
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Python
    Programming Languages
  • Linkedin
    Widgets

Media & News

Quell Therapeutics's Email Address Formats

Quell Therapeutics uses at least 1 format(s):
Quell Therapeutics Email FormatsExamplePercentage
F.Last@quell-tx.comJ.Doe@quell-tx.com
95%
FLast@quell-tx.comJDoe@quell-tx.com
3%
First.Last@quell-tx.comJohn.Doe@quell-tx.com
1%
FirstL@quell-tx.comJohnD@quell-tx.com
1%

Frequently Asked Questions

Where is Quell Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Quell Therapeutics's main headquarters is located at 80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ GB. The company has employees across 4 continents, including EuropeNorth AmericaAfrica.

What is Quell Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Quell Therapeutics's official website is quell-tx.com and has social profiles on LinkedIn.

How much revenue does Quell Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Quell Therapeutics's annual revenue reached $15M.

What is Quell Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Quell Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quell Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Quell Therapeutics has approximately 158 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Executive Officer: S. H.Chief Medical Officer: L. D.Chief Manufacturing Officer: A. V.. Explore Quell Therapeutics's employee directory with LeadIQ.

What industry does Quell Therapeutics belong to?

Minus sign iconPlus sign icon
Quell Therapeutics operates in the Biotechnology Research industry.

What technology does Quell Therapeutics use?

Minus sign iconPlus sign icon
Quell Therapeutics's tech stack includes jsDelivrNeo4jADPSlickGoogleMicrosoftPythonLinkedin.

What is Quell Therapeutics's email format?

Minus sign iconPlus sign icon
Quell Therapeutics's email format typically follows the pattern of . Find more Quell Therapeutics email formats with LeadIQ.

How much funding has Quell Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Quell Therapeutics has raised $156M in funding. The last funding round occurred on Nov 29, 2021 for $156M.

When was Quell Therapeutics founded?

Minus sign iconPlus sign icon
Quell Therapeutics was founded in 2019.
Quell Therapeutics

Quell Therapeutics

Biotechnology ResearchLondon, United Kingdom51-200 Employees

An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.

Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.

Section iconCompany Overview

Headquarters
80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $156M

    Quell Therapeutics has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $156M.

  • $10M$50M

    Quell Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $156M

    Quell Therapeutics has raised a total of $156M of funding over 3 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $156M.

  • $10M$50M

    Quell Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.